Almirall, S.A. (BME: ALM)
Spain
· Delayed Price · Currency is EUR
8.71
-0.03 (-0.34%)
Jan 20, 2025, 5:35 PM CET
Almirall Revenue
Almirall had revenue of 231.12M EUR in the quarter ending September 30, 2024, with 10.44% growth. This brings the company's revenue in the last twelve months to 953.49M, up 5.12% year-over-year. In the year 2023, Almirall had annual revenue of 898.79M with 2.31% growth.
Revenue (ttm)
953.49M
Revenue Growth
+5.12%
P/S Ratio
1.95
Revenue / Employee
500.78K
Employees
1,904
Market Cap
1.86B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 898.79M | 20.28M | 2.31% |
Dec 31, 2022 | 878.51M | 42.01M | 5.02% |
Dec 31, 2021 | 836.50M | 22.01M | 2.70% |
Dec 31, 2020 | 814.49M | -96.17M | -10.56% |
Dec 31, 2019 | 910.66M | 99.68M | 12.29% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Grifols | 7.01B |
Laboratorios Farmaceuticos Rovi | 799.25M |
Pharma Mar | 167.00M |
Faes Farma | 504.04M |
Clínica Baviera | 252.47M |
Atrys Health | 211.11M |
Laboratorio Reig Jofre | 333.69M |
Prim, S.A. | 227.57M |
Almirall News
- 2 months ago - Almirall, S.A. (LBTSF) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Almirall, S.A. reports nine-month 2024 results; reaffirms FY24 outlook - Seeking Alpha
- 6 months ago - Almirall, S.A. (LBTSF) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 9 months ago - Almirall, S.A. (LBTSF) Q1 2024 Earnings Call Transcript - Seeking Alpha
- 9 months ago - Almirall Delivers Strong Start of 2024 – Q1 Net Sales Growth of 6.6% Overall and 18% in the European Dermatology Business, Driven by Biologics and Solid Performance of Broad Product Portfolio - Business Wire
- 1 year ago - Almirall, S.A. (LBTSF) Q4 2023 Earnings Call Transcript - Seeking Alpha
- 1 year ago - Almirall, S.A. (LBTSF) Q3 2023 Earnings Call Transcript - Seeking Alpha
- 1 year ago - Almirall, S.A. (LBTSF) Q2 2023 Earnings Call Transcript - Seeking Alpha